Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Etiology
100%
Molecular Mechanism
100%
End-stage Liver Disease
100%
Sarcopenia
100%
Driver Mechanism
100%
Hepatocyte Growth Factor
30%
Healthy Controls
30%
Interleukin-1β
23%
Growth Differentiation factor-15 (GDF-15)
23%
Differentially Expressed Genes
15%
Disease Control
15%
Myotubes
15%
RNA Sequencing (RNA-seq)
15%
Human Myotubes
15%
Clinical Trials
7%
Metabolism
7%
Glycolysis
7%
Quality of Life
7%
Quantitative PCR
7%
Serum Concentration
7%
Subgroup Analysis
7%
Immunofluorescence Microscopy
7%
Oxidative Phosphorylation (OXPHOS)
7%
Cytokine Profile
7%
Interleukin-1 Receptor Antagonist (IL-1Ra)
7%
Skeletal muscle
7%
Qiagen
7%
Increased Mortality
7%
Muscle Mass
7%
Physiological Concentrations
7%
Dysregulated
7%
Total RNA
7%
Muscle Function
7%
Quadriceps muscle
7%
Disease Etiology
7%
Viral Hepatitis
7%
Path Analysis
7%
Mitochondrial Function
7%
Cellular Senescence
7%
Specific Mechanisms
7%
Snapping
7%
Targeted Therapy
7%
Muscle Tissue
7%
Muscle Biopsy
7%
Non-alcoholic Fatty Liver Disease (NAFLD)
7%
Plasma Treatment
7%
Skeletal muscle Mass
7%
Vastus Lateralis muscle
7%
Ethical Approval
7%
Interleukin-1 Signaling
7%
Luminex
7%
Illumina
7%
Stratified Analysis
7%
Circulating Factors
7%
Fusion Index
7%
Metabolic Flux
7%
Senescence Pathways
7%
Hepatitis Other
7%
Ingenuity
7%
Nuclear Fusion
7%
Skeletal muscle Quality
7%
Liver Disease Etiology
7%
DESeq2
7%
Therapeutic Interventions
7%
Serum Profiling
7%
Flux Assay
7%
Transcriptomic Profile
7%
Alcohol-related
7%
Thickness Function
7%
Upstream Regulator Analysis
7%
Epitranscriptomic Modification
7%
Aged Donors
7%
Immunology and Microbiology
Cytokine
100%
Interleukin 1
100%
Hepatocyte Growth Factor
100%
Myotube
100%
Blood Plasma
75%
Growth Differentiation Factor 15
75%
Skeletal Muscle
50%
RNA Sequence
50%
Transcriptomics
50%
Muscle
50%
In Vitro
50%
ELISA
25%
Blood Level
25%
Immunofluorescence
25%
Oxidative Phosphorylation
25%
Fibrinogen
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Hepatitis Virus
25%
Muscle Tissue
25%
Vastus Lateralis Muscle
25%
Interleukin 1 Receptor Antagonist
25%
Ribonucleic Acid
25%
Glycolysis
25%
Viral Hepatitis
25%
Biochemistry, Genetics and Molecular Biology
Cytokine
100%
Hepatocyte Growth Factor
100%
Interleukin-1
100%
Molecular Mechanism
100%
Blood Plasma
75%
Skeletal Muscle
50%
Transcriptomics
50%
RNA Sequence
50%
Differentially Expressed Gene
50%
Genomics
25%
Metabolic Pathway
25%
RNA
25%
Blood Level
25%
Immunofluorescence
25%
Oxidative Phosphorylation
25%
Interleukin 1 Receptor Antagonist
25%
Clinical Trial
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
25%
Metabolic Flux
25%
Hepatitis Virus
25%
Targeted Therapy
25%
Albendazole
25%
Glycolysis
25%
Medicine and Dentistry
End Stage Liver Disease
100%
Sarcopenia
100%
Etiology
100%
Cytokine
30%
Scatter Factor
30%
Interleukin 1
30%
Myotube
30%
Growth Differentiation Factor 15
23%
In Vitro
15%
Skeletal Muscle
15%
Transcriptomics
15%
RNA Sequence
15%
Clinical Trial
7%
Quality of Life
7%
Subgroup Analysis
7%
Enzyme Linked Immunosorbent Assay
7%
Fibrinogen
7%
Targeted Therapy
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Hepatitis Virus
7%
Cellular Senescence
7%
Muscle Biopsy
7%
Interleukin 1 Receptor Blocking Agent
7%
Immunofluorescence Microscopy
7%
Oxidative Phosphorylation
7%
Vastus Lateralis Muscle
7%
Non-Alcoholic Fatty Liver Disease
7%
Flux Assay
7%
Diseases
7%
Genetics
7%
Glycolysis
7%